Cargando…

Combining pharmacophore- and MD-based modelling for phase II metabolism prediction

Detalles Bibliográficos
Autores principales:	Rakers, Christin, Wolber, Gerhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980176/ https://www.ncbi.nlm.nih.gov/pubmed/24765113 http://dx.doi.org/10.1186/1758-2946-6-S1-O15

Ejemplares similares

3D pharmacophore alignments: does improved geometric accuracy affect virtual screening performance?
por: Wolber, Gerhard, et al.
Publicado: (2010)

Virtual screening using structure-based consensus pharmacophore models and ensemble docking based on MD-generated conformations
por: Koch, Oliver, et al.
Publicado: (2011)

Efficient 3D pharmacophore alignment as a tool for structure-based modeling and scoring
por: Wolber, Gerhard
Publicado: (2008)

Tautomerism in structure-based 3D pharmacophore modeling
por: Seidel, Thomas, et al.
Publicado: (2008)

KRIPO – a structure-based pharmacophores approach explains polypharmacological effects
por: Ritschel, Tina, et al.
Publicado: (2014)

Generation of structure-based pharmacophores using energetic analysis – application on fragment docking
por: Loving, Kathryn, et al.
Publicado: (2011)

Design of dual ligands using excessive pharmacophore query alignment
por: Moser, Daniel, et al.
Publicado: (2012)

Using structure- and Ligand-based pharmacophores as filters to discriminate Human Aryl Sulfotransferase 1A1 (SUL1A1) binders into substrates and inhibitors
por: Soliman, Salwa M, et al.
Publicado: (2014)

Using meta-analysis of Phase II trials to predict Phase III trial results
por: Burke, Danielle, et al.
Publicado: (2013)

Neoadjuvant treatment: the MD Anderson experience
por: Hortobagyi, GN
Publicado: (2005)

Balancing selectivity vs stability using molecular dynamics and umbrella sampling
por: Mortier, Jeremie, et al.
Publicado: (2014)

A ligand-based 3D pharmacophore model for the μ opioid receptor: application to the morphinan class of opioids
por: Asim, Muhammad Faheem, et al.
Publicado: (2010)

Preliminary results from a Phase I/II study of epacadostat (incb024360) in combination with pembrolizumab in patients with selected advanced cancers
por: Gangadhar, Tara C, et al.
Publicado: (2015)

Topological pharmacophores: pros & cons of QSARs based on 2D pharmacophore fingerprints
por: Horvath, D
Publicado: (2008)

A series of decision-theoretic phase II trials of related treatments
por: Hee, Siew Wan, et al.
Publicado: (2013)

Predicting cyclooxygenase inhibition by three-dimensional pharmacophoric profiling. Part II: Identification of enzyme inhibitors from Prasaplai, a Thai traditional medicine
por: Waltenberger, Birgit, et al.
Publicado: (2011)

Comparing active treatments at phase II: using multiple criteria to find the optimal treatment to take forward to phase III
por: Sweeting, Michael, et al.
Publicado: (2013)

Combining dissimilarity based classifiers for cancer prediction using gene expression profiles
por: Blanco, Ángela, et al.
Publicado: (2007)

Modelling phase precession in the hippocampus
por: Chadwick, Angus, et al.
Publicado: (2015)

Design choices for small-scale phase II trials with non-inferiority (NI) intention
por: Sun, Hong, et al.
Publicado: (2011)

Using continuous data on tumour measurements to improve inference in phase II cancer studies
por: Wason, James, et al.
Publicado: (2013)

pharmACOphore: multiple flexible ligand alignment based on ant colony optimization
por: Hessler, Gerhard, et al.
Publicado: (2010)

Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia
por: Yap, Christina, et al.
Publicado: (2011)

Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation
por: Schuster, Daniela, et al.
Publicado: (2011)

Pharmacophore-based discovery of FXR-agonists. Part II: Identification of bioactive triterpenes from Ganoderma lucidum
por: Grienke, Ulrike, et al.
Publicado: (2011)

An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information
por: Stallard, Nigel
Publicado: (2011)

Combining multiple predictive markers in stratified medicine
por: Emsley, Richard, et al.
Publicado: (2015)

A Bayesian dose-finding procedure applied to a seamless phase I/II trial in rheumatoid arthritis
por: Whitehead, Anne, et al.
Publicado: (2011)

Model-based prediction of fusimotor activity during active wrist movements
por: Grandjean, Bernard, et al.
Publicado: (2013)

Phenotyping asthma using an unsupervised prediction model based on blood granulocyte responsiveness
por: Hilvering, Bart, et al.
Publicado: (2015)

Tumor necrosis factor alpha – an useful biomarker in a combined predictive model for liver fibrosis staging in patients with chronic HCV infection
por: Munteanu, Daniela-Ioana, et al.
Publicado: (2014)

EuroSCORE II and the importance of a local model, InsCor
por: Lisboa, L, et al.
Publicado: (2013)

Comparison of a frequentist and Bayesian response-adaptive randomisation approach in multi-stage phase II selection trials with multiple experimental arms
por: Yap, Christina, et al.
Publicado: (2015)

In silico identification of novel PKC βII inhibitors: ligand and receptor based pharmacophore modeling, virtual screening, and molecular dynamics study
por: Grewal, Baljinder K, et al.
Publicado: (2012)

Intra-operative high intensity focused ultrasound in patients with colorectal liver metastases: results of a phase I-II study in 21 patients
por: Melodelima, David, et al.
Publicado: (2015)

Performance of EuroSCORE II in the prediction of in-hospital death after on pump versus off pump CABG
por: Sales, M, et al.
Publicado: (2013)

Differences in Fat Metabolism Between Predicted Survivors And Non-Survivors of Faecal Peritonitis
por: Kleyman, A, et al.
Publicado: (2015)

Screening MRI-based prediction model for therapeutic response of MR-HIFU ablation of uterine fibroids
por: Kim, Young-sun, et al.
Publicado: (2015)

Automatic pharmacophore model generation using weighted substructure assignments
por: Jahn, Andreas, et al.
Publicado: (2010)

Pharmacophore-based discovery of a novel cytosolic phospholipase A(2)α inhibitor
por: Noha, Stefan M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_u30tnhcmtbjsuk1au44k490gjc